Clinical Trial

A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to assess the immunogenicity and safety of EV71 vaccine (Envacgen®) in Children Aged 6 to \<10 Years compared to Children Aged 2 to \<6 Years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-10.
Status change: Recruiting → Active, Not Recruiting 2026-04-28
Trial Details
NCT Number NCT07178522
Lead Sponsor Medigen Vaccine Biologics Corp.
Conditions Enterovirus 71 Inactivated Vaccine
Enrollment 378 participants
Start Date 2025-06-25
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-04